Related Experiment Video

Updated: Mar 25, 2026

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

7.9K

Discovery of novel natural compounds as PKCθ inhibitors: structure-based virtual screening and in vitro evaluation

Salim Baali1,2, Nacira Abidli3, Parthiban Marimuthu4

  • 1Department of Ecology and Environmental Engineering, University of 8th May, 1945 Guelma, BP 401, 24000, Guelma, Algeria. baali.salim@univ-guelma.dz.

Journal of Computer-Aided Molecular Design
|March 23, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
CancerKinase inhibitorMolecular dynamics simulationNatural compoundProtein kinase C thetaVirtual screening

More Related Videos

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.6K
Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
10:25

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on: November 22, 2024

756

Related Experiment Videos

Last Updated: Mar 25, 2026

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

7.9K
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.6K
Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
10:25

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on: November 22, 2024

756

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

12.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.9K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

2.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.0K

Articles linked to this work by shared authors, journal, and citation graph.

In Silico Identification of Novel Leads as Potential DPP-IV Inhibitors as Antidiabetic Agents Using Virtual Screening.

ACS omega·2026

Selective transport of plasma-derived reactive species through the plant aquaporin channels: a molecular dynamics study.

Scientific reports·2026

Immunopathogenesis of TB-HIV Co-Infection: Mechanisms of Dual Immune Suppression and Viral-Bacterial Synergy.

Virology·2026

New insights into SREB orphan receptor roles in the ovary, using comparative transcriptomics across 3 fishes.

Endocrinology·2026

High-sensitivity, protein-independent detection of dsDNA sequences.

Proceedings of the National Academy of Sciences of the United States of America·2026

Subtype-specific structural features of the hearing loss-associated human P2X2 receptor.

Proceedings of the National Academy of Sciences of the United States of America·2025

Design, synthesis, in vivo, and in silico evaluation of novel quinoline-based dihydrothiazoles as anticonvulsants.

Journal of computer-aided molecular design·2026

Ligand-induced reshaping of the conformational free energy landscape drives dynamic restriction in Trypanosoma brucei alternative oxidase.

Journal of computer-aided molecular design·2026

Quantum-mechanical insights into sodium alginate gelation and AI-driven discovery of synthetic biomimetic analogs.

Journal of computer-aided molecular design·2026

Identification of potential SARS-CoV-2 Mpro inhibitors from a Thai natural product database via interaction fingerprint-based virtual screening.

Journal of computer-aided molecular design·2026

Structure-guided identification and experimental validation of NAT10-targeting small molecules in colorectal cancer cells.

Journal of computer-aided molecular design·2026

Docking-score landscapes shape active-learning performance across Vina, Glide, and SILCS.

Journal of computer-aided molecular design·2026

Pharmacovigilance in the treatment of cutaneous leishmaniasis: adverse event profile at a reference center.

Revista da Sociedade Brasileira de Medicina Tropical·2026

Total synthesis as a critical tool for structural revision of natural products.

Chemical communications (Cambridge, England)·2026

Progress on quinoline‑based antitumour agents: Mechanistic insights and optimization strategies (Review).

Molecular medicine reports·2026

Disproportionate reporting of seizures with histamine H1 receptor antagonists: The role of drug generation and brain H1 receptor occupancy assessed using the Japanese Adverse Drug Event Report database.

International journal of clinical pharmacology and therapeutics·2026

Discovery of tricyclic benzo[4,5]imidazo[2,1-b]thiazole-3-hydroxyindolin-2-one hybrids as selective MAO-B and cholinesterase inhibitors.

RSC advances·2026

Simultaneous exploitation of phaeanthine - a bisbenzylisoquinoline alkaloid for dual anti-metastatic and anti-angiogenic potential by disruption of Akt/NF-κB/MMP regulatory pathways.

RSC medicinal chemistry·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us